Cloudbyz CTMS’ Post

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tfV8V0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfNQ30 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce Salesforce

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tf-xt0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfVqK0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce

🔬Explore how #artificialintelligence and #machinelearning can significantly transform #pharmacovigilance practices. Our comprehensive resource delves into the potential of #AI and #ML technologies in automating adverse event detection, signal detection, and safety monitoring. Read more at: https://hubs.li/Q02tfNNj0 Interested in learning about our Safety and PV solutions? Read more here: https://hubs.li/Q02tfV8T0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety #Salesforce

🔬 Transforming #pharmacovigilance and ensuring drug/device safety with #AI and #ML. AI/ML algorithms are significantly transforming the way safety data is analyzed, adverse events are detected, and risks are mitigated. Read on to explore some of the key AI/ML use cases in pharmacovigilance and drug/device safety: https://hubs.li/Q02nqCZ00 Sign up for our webinar: "From Legacy to Leading Edge: Embracing Next-Gen CTMS" on Thursday, March 28 2024, at 11 AM EST: https://hubs.li/Q02nqBHF0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials #DrugSafety #ArtificialIntelligence #MachineLearning #PatientSafety

Impact of Digital Transformation on Pharmacovigilance Efficiency and Accuracy In a recent conversation with #IndiaPharmaOutlook magazine in order to shed light on the ways in which pharmacovigilance outsourcing is undergoing pivotal transformation. Catch the full story here: https://goo.su/KiggId Gurpreet Singh, VP, MD (Integrated Safety), IQVIA #digitaltransformation #pharmacovigilanceindustry #artificialintelligence #MachineLearning #pharmaceutical 

𝙈𝙖𝙧𝙠𝙚𝙩 𝙂𝙧𝙤𝙬𝙩𝙝, 𝙆𝙚𝙮 𝘿𝙧𝙞𝙫𝙚𝙧𝙨, 𝙖𝙣𝙙 𝙩𝙝𝙚 𝙋𝙤𝙬𝙚𝙧 𝙤𝙛 𝘼𝙪𝙩𝙤𝙢𝙖𝙩𝙞𝙤𝙣 𝙞𝙣 📚𝙈𝙚𝙙𝙞𝙘𝙖𝙡 𝙇𝙞𝙩𝙚𝙧𝙖𝙩𝙪𝙧𝙚 𝙈𝙤𝙣𝙞𝙩𝙤𝙧𝙞𝙣𝙜 Exciting news in the world of drug safety and #pharmacovigilance! The global market for these crucial solutions was valued at $8.39 billion in 2023 and is expected to soar to $14.96 billion by 2031, growing 📈at a robust CAGR of 7.5% from 2024 to 2031. Key drivers of this growth include the rising prevalence of adverse drug reactions and the increasing demand for effective 💊drug safety monitoring systems. Major #pharmaceutical companies are ramping up investments in drug development, and regulatory authorities are increasingly adopting pharmacovigilance services to ensure public safety. Additionally, advanced technologies like artificial intelligence 🦾and big data analytics are revolutionizing the field. One critical aspect of pharmacovigilance is the monitoring of medical literature, which requires strategic investment. The choice between manual and automated #literature searches can significantly impact efficiency and cost-effectiveness. 🚀In our latest blog article, we explore the economic benefits of automated solutions for screening medical literature. 🔥Check out the blog to learn how automation can streamline your pharmacovigilance efforts: https://lnkd.in/dmWfBm-f

Pharmacovigilance is crucial in ensuring the safety of medications. It involves monitoring, assessing, and preventing adverse effects or any other drug-related problems. Here are some important aspects: Reporting Adverse Events: Healthcare professionals, patients, and pharmaceutical companies should report any suspected adverse reactions to regulatory authorities. Timely reporting helps in early detection and intervention. Artificial Intelligence (AI) Integration: Pharmacovigilance is increasingly leveraging AI and machine learning algorithms to enhance signal detection, automate case processing, and improve data analysis. These technologies enable faster and more accurate identification of potential safety concerns from large volumes of data, leading to more proactive risk management. Real-World Evidence (RWE): Utilizing real-world data from sources like electronic health records, wearable devices, and social media platforms is becoming integral to pharmacovigilance. RWE provides insights into medication use patterns, treatment outcomes, and adverse events in diverse patient populations and settings, complementing traditional clinical trial data. Regulatory Compliance: Pharmaceutical companies must comply with pharmacovigilance regulations set by regulatory agencies such as the FDA (U.S. Food and Drug Administration) or EMA (European Medicines Agency). Non-compliance can lead to regulatory actions. pharmacovigilance plays a critical role in safeguarding public health by ensuring that the benefits of medications outweigh their risks and by promoting the safe and effective use of drugs.

The application of AI in patient monitoring and post-marketing surveillance is at the top of Clientelis solutions pipeline

🔬💡 Cutting Pharmacovigilance Costs with AI Pharmacovigilance, the practice of monitoring drug safety, is compulsory but costly. The average cost per case is $90 (Deloitte). With cases rising tenfold over the past 20 years and continuing to grow at 15% annually (FDA), there's a clear need for efficiency. The burden of regulation by authorities like the FDA, WHO, and EMA is also increasing. These organizations are implementing stricter guidelines and requirements for monitoring and reporting adverse drug reactions. This heightened regulatory scrutiny, while crucial for patient safety, adds to the workload and costs for pharmaceutical companies. AI as a Solution: AI is transforming pharmacovigilance by automating data collection and analysis, improving signal detection, streamlining reporting, and enhancing predictive capabilities. These advancements can reduce the need for extensive human resources and minimize errors, leading to significant cost savings. AI also facilitates outsourcing tasks to qualified professionals in low-cost regions, further reducing expenses while maintaining high standards. Estimated Cost and Time Savings: Cost Savings: Automating tasks can cut the average cost per case by up to 50%.  Time Savings: AI can reduce the time required for data processing and reporting by up to 70%, completing tasks in days instead of weeks. Outsourcing Benefits: Outsourcing AI-driven tasks to low-cost regions can further cut operational costs by 20-30%. Integrating AI into pharmacovigilance processes offers substantial cost reductions and improved drug safety. Clientelis is at the forefront of AI-powered pharmaceutical services. 🚀 #AI #Pharmacovigilance #HealthcareInnovation #PatientSafety #CostEfficiency #Clientelis #Surveillance #Postmarketing #AdverseEvent #PharmaceuticalServices #BPO #PV #Materiovigilance #PharmaceuticalServices #Compliance